Austin Aerts Sells 2,431 Shares of Sera Prognostics, Inc. (NASDAQ:SERA) Stock

Sera Prognostics, Inc. (NASDAQ:SERA) CFO Austin Aerts sold 2,431 shares of the stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $8.06, for a total transaction of $19,593.86. Following the sale, the chief financial officer now owns 283,325 shares in the company, valued at $2,283,599.50. The trade was a 0.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Austin Aerts also recently made the following trade(s):

• On Monday, November 11th, Austin Aerts sold 7,179 shares of Sera Prognostics stock. The shares were sold at an average price of $7.32, for a total transaction of $52,550.28.

Sera Prognostics Stock Down 0.2 %

NASDAQ:SERA opened at $6.60 on Friday. Sera Prognostics, Inc. has a twelve month low of $4.98 and a twelve month high of $12.35. The stock’s 50-day simple moving average is $7.40 and its 200 day simple moving average is $7.31.

Sera Prognostics (NASDAQ:SERA) last posted its earnings results on Wednesday, November 6th. The company reported ($0.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.02). The firm had revenue of $0.03 million for the quarter, compared to analysts’ expectations of $0.09 million. During the same period in the prior year, the business earned ($0.23) earnings per share. As a group, sell-side analysts predict that Sera Prognostics, Inc. will post -0.96 EPS for the current year.

Institutional Trading of Sera Prognostics

Hedge funds have recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. increased its holdings in shares of Sera Prognostics by 7,357.8% during the third quarter. JPMorgan Chase & Co. now owns 884,867 shares of the company’s stock worth $6,902,000 after buying an additional 873,002 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Sera Prognostics by 8.9% during the 3rd quarter. Geode Capital Management LLC now owns 586,837 shares of the company’s stock valued at $4,578,000 after acquiring an additional 47,969 shares in the last quarter. State Street Corp grew its position in Sera Prognostics by 8.8% during the 3rd quarter. State Street Corp now owns 425,093 shares of the company’s stock worth $3,316,000 after acquiring an additional 34,479 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in Sera Prognostics by 100.2% in the 2nd quarter. Bank of New York Mellon Corp now owns 150,708 shares of the company’s stock worth $892,000 after purchasing an additional 75,441 shares in the last quarter. Finally, Sanders Morris Harris LLC raised its position in Sera Prognostics by 165.7% in the fourth quarter. Sanders Morris Harris LLC now owns 90,600 shares of the company’s stock valued at $725,000 after purchasing an additional 56,500 shares during the last quarter. Institutional investors and hedge funds own 54.64% of the company’s stock.

Sera Prognostics Company Profile

Sera Prognostics, Inc, a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies.